PRESS-RELEASE ·Filed Nov 16, 2026
Press release · Earnings
ACRV drugs
ACRV drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3404102 |
Track record
8 reports on ACRV
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Viewing Entry $1.45 Now $1.46 +0.69% settles Feb 16
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.57 Now $1.46 −7.01% settles Feb 9
- Nov 6, 202610d ago 8-K Neutral 5/10 Entry $1.61 Now $1.46 −9.32% settles Feb 4
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $1.61 Now $1.46 −9.32% settles Feb 4
- Jul 21, 202616w ago Press Release Neutral 3/10 Entry $1.68 to $1.76 Now $1.46 −13.10% ▲ +4.76% +1.50% vs SPY
- May 22, 202625w ago DEFA14A Neutral 3/10 Entry $1.67 to $2.39 Now $1.46 −12.57% ▲ +43.11% +40.39% vs SPY
- Apr 30, 202628w ago DEFA14A Neutral 2/10 Entry $1.85 to $1.56 Now $1.46 −21.08% ▼ −15.68% −18.78% vs SPY
- Mar 19, 202634w ago Press Release Bullish 8/10 Entry $1.70 to $1.52 Now $1.46 −14.12% ▼ −10.59% −24.93% vs SPY
Showing 8 of 8
US Market Status
Market Closed · Opens in 8h 32m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers